Government Report Concludes That SAM-e Decreases Joint Discomfort
Ridgefield
CT, 19 December 2002
A
report issued by the U.S. Department of Health and Human Services
Agency for Healthcare Research and Quality concludes that SAM-e
is effective for joint discomfort.
Entitled
"S-Adenosyl-L-Methionine for Treatment of Depression, Osteoarthritis,
and Liver Disease," the report conducted a search of the published
literature on the use of SAM-e within several areas and, on the
basis of that search, evaluated the evidence for the efficacy of
SAM-e. Of the studies measured, 10 were included in a meta-analysis
of the efficacy of SAM-e to decrease joint discomfort. The data
indicated that "SAM-e is more effective than placebo" and that it
was shown to be "equivalent to standard therapy," according to the
scientific review.
"The
results of this compelling report reiterate what many have believed
all alongthat SAM-e is indeed a promising and natural alternative
for joint discomfort associated with everyday activities," said
Barbara Levine, a board member of the Pharmaton Institute for Wellness.
Pharmaton
Natural Health Products, a leading marketer of natural supplements,
offers two products with SAM-e to meet the needs of a growing number
of Americans who are looking for ways to help support their joint
health.
The
Department of Health and Human Services Agency for Healthcare Research
and Quality is expected to post the full SAM-e Evidence Report on
its website.
Source
Pharmaton
Institute for Wellness, manufacturers of two Flexium products
that contain SAM-e.
|